These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8978937)

  • 41. A 20-year longitudinal observational study of somatic antidepressant treatment effectiveness.
    Leon AC; Solomon DA; Mueller TI; Endicott J; Rice JP; Maser JD; Coryell W; Keller MB
    Am J Psychiatry; 2003 Apr; 160(4):727-33. PubMed ID: 12668362
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The persistence of the placebo response in antidepressant clinical trials.
    Khan A; Redding N; Brown WA
    J Psychiatr Res; 2008 Aug; 42(10):791-6. PubMed ID: 18036616
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design characteristics that influence attrition in geriatric antidepressant trials: meta-analysis.
    Heo M; Papademetriou E; Meyers BS
    Int J Geriatr Psychiatry; 2009 Sep; 24(9):990-1001. PubMed ID: 19263464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between depression severity entry criteria and antidepressant clinical trial outcomes.
    Khan A; Schwartz K; Kolts RL; Ridgway D; Lineberry C
    Biol Psychiatry; 2007 Jul; 62(1):65-71. PubMed ID: 17141744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. L-methylfolate (Deplin) for depression.
    Med Lett Drugs Ther; 2010 Apr; 52(1336):31-2. PubMed ID: 20407417
    [No Abstract]   [Full Text] [Related]  

  • 46. Quality of life measurement in antidepressant trials. Is there an added value?
    De Fruyt J; Demyttenaere K
    Psychother Psychosom; 2009; 78(4):212-9. PubMed ID: 19401621
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Burdens and benefits of placebos in antidepressant clinical trials: a decision and cost-effectiveness analysis.
    Kim SY; Holloway RG
    Am J Psychiatry; 2003 Jul; 160(7):1272-6. PubMed ID: 12832241
    [TBL] [Abstract][Full Text] [Related]  

  • 48. General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.
    Baghai TC; Blier P; Baldwin DS; Bauer M; Goodwin GM; Fountoulakis KN; Kasper S; Leonard BE; Malt UF; Stein D; Versiani M; Möller HJ;
    Eur Arch Psychiatry Clin Neurosci; 2011 Nov; 261 Suppl 3():207-45. PubMed ID: 22033583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New strategies for treating chronic depression.
    Kocsis JH
    J Clin Psychiatry; 2000; 61 Suppl 11():42-5. PubMed ID: 10926054
    [TBL] [Abstract][Full Text] [Related]  

  • 50. If depression meds don't work, switching sooner may be best.
    Harv Mens Health Watch; 2012 Nov; 17(4):8. PubMed ID: 23330207
    [No Abstract]   [Full Text] [Related]  

  • 51. A comparative meta-analysis of Clinical Global Impressions change in antidepressant trials.
    Spielmans GI; McFall JP
    J Nerv Ment Dis; 2006 Nov; 194(11):845-52. PubMed ID: 17102709
    [TBL] [Abstract][Full Text] [Related]  

  • 52. How can we know whether antidepressants increase suicide risk?
    Simon GE
    Am J Psychiatry; 2006 Nov; 163(11):1861-3. PubMed ID: 17074930
    [No Abstract]   [Full Text] [Related]  

  • 53. The current crisis of confidence in antidepressants.
    Nierenberg AA; Leon A; Price LH; Shelton RC; Trivedi MH
    J Clin Psychiatry; 2011 Jan; 72(1):27-33. PubMed ID: 21272514
    [No Abstract]   [Full Text] [Related]  

  • 54. [Antidepressive treatments. Predictive factors of tolerability].
    Gérard A; Susini JR
    Encephale; 1991 Dec; 17 Spec No 3():411-4. PubMed ID: 1807967
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pro and con: Antidepressants also for mild depression?].
    Hegerl U
    MMW Fortschr Med; 2011 Jul; 153(29-31):30. PubMed ID: 21830734
    [No Abstract]   [Full Text] [Related]  

  • 56. Antidepressants on trial: how valid is the evidence?
    Parker G
    Br J Psychiatry; 2009 Jan; 194(1):1-3. PubMed ID: 19118316
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Research directions for treatment of depression.
    Finkel SI
    Int Psychogeriatr; 1995; 7 Suppl():139-42. PubMed ID: 8580389
    [No Abstract]   [Full Text] [Related]  

  • 58. Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders.
    Baghai TC; Blier P; Baldwin DS; Bauer M; Goodwin GM; Fountoulakis KN; Kasper S; Leonard BE; Malt UF; Stein DJ; Versiani M; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2012 Feb; 262(1):13-22. PubMed ID: 22083391
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Switching antidepressant drug therapy helps some patients some of the time--what TORDIA, STAR*D, and observational research have taught us about treatment-resistant depression.
    Curtiss FR; Fairman KA
    J Manag Care Pharm; 2008 Jun; 14(5):468-73. PubMed ID: 18597577
    [No Abstract]   [Full Text] [Related]  

  • 60. The three-fold Hamilton Depression Scale: an editorial comment to Isacsson G, Adler M. Randomized clinical trials underestimate the efficacy of antidepressants in less severe depression (1).
    Bech P
    Acta Psychiatr Scand; 2012 Jun; 125(6):423-4. PubMed ID: 22574930
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.